Stay updated on Fremanezumab, Migraine, Sleep Clinical Trial
Sign up to get notified when there's something new on the Fremanezumab, Migraine, Sleep Clinical Trial page.

Latest updates to the Fremanezumab, Migraine, Sleep Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe record history now shows revision v3.5.0 added and v3.4.3 removed; no substantive content changes to the study details are reflected.SummaryDifference0.1%

- Check31 days agoChange DetectedFooter revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check38 days agoChange DetectedAdded entries noting poor enrollment and that results have been posted, with updates to Outcome Measures (Results), Outcome Measures, and Study Status. A prior narrative about enrollment difficulties and termination was deleted.SummaryDifference0.8%

- Check46 days agoChange DetectedReturned: 2026-02-24 with updates to core study content including Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow, Arms/Interventions, and Study Status, and a note that Quality Control Review Has Not Concluded.SummaryDifference1%

- Check60 days agoChange DetectedAdded history entries for 'Results Submitted' and 'Revision: v3.4.2'. Removed older items including 'No Results Posted', 'Revision: v3.4.1', and the government funding notice.SummaryDifference0.9%

- Check67 days agoChange DetectedA site-wide funding-status notice was added and the revision label updated to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

Stay in the know with updates to Fremanezumab, Migraine, Sleep Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fremanezumab, Migraine, Sleep Clinical Trial page.